Karkkainen, M J <br/><br/>
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.  [electronic resource] 

 -  Nature genetics  Jun 2000 
 - 153-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1061-4036 
<br/><br/><label>Standard No.: </label>10.1038/75997  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Animals<br/>Cell Line<br/>Chromosomes, Human, Pair 5--genetics<br/>Endothelial Growth Factors--pharmacology<br/>Enzyme Stability<br/>Female<br/>Genes, Dominant--genetics<br/>Half-Life<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Lymphedema--congenital<br/>Male<br/>Mice<br/>Models, Molecular<br/>Molecular Sequence Data<br/>Mutation, Missense--genetics<br/>Pedigree<br/>Phosphorylation--drug effects<br/>Protein Structure, Secondary<br/>Receptor Protein-Tyrosine Kinases--chemistry<br/>Receptors, Cell Surface--chemistry<br/>Recombinant Fusion Proteins--chemistry<br/>Signal Transduction--drug effects<br/>Transcriptional Activation--drug effects<br/>Vascular Endothelial Growth Factor C<br/>Vascular Endothelial Growth Factor Receptor-3